On Minimizing Risk and Harm in the Use of Psychedelics
The authors outline important gaps in our knowledge around the safety and risk profile of psychedelic medicines and identify practical steps forward for researchers and clinical practitioners to make this promising field safer.
Authors
- William Brennan
- Tehseen Noorani (ORCID: https://orcid.org/0000-0002-4185-0218)
- Michiel van Elk (ORCID: https://orcid.org/0000-0002-7631-3551)
- Peter S. Hendricks (ORCID: https://orcid.org/0009-0004-8642-9584)
- Jakub Greń (ORCID: https://orcid.org/0000-0002-1286-5306)
- B. Anderson (ORCID: https://orcid.org/0000-0001-5023-660X)
- Daniel J. Kruger (ORCID: https://orcid.org/0000-0002-2757-7016)
- Edward Jacobs (ORCID: https://orcid.org/0000-0002-2622-7233)
- David S. Mathai (ORCID: https://orcid.org/0000-0001-9972-601X)
- Kristin Nash
- Rebecka Bremler
- Oliver Robinson (ORCID: https://orcid.org/0000-0002-6758-2223)
- Nicky J. Mehtani (ORCID: https://orcid.org/0000-0003-4277-6889)
- Robin Lester Carhart-Harris (ORCID: https://orcid.org/0000-0002-6062-7150)
- David B. Yaden (ORCID: https://orcid.org/0000-0002-9604-6227)
- Amy L. McGuire (ORCID: https://orcid.org/0000-0002-7819-519X)
- Tomislav Majić (ORCID: https://orcid.org/0000-0003-2950-6673)
- Otto Simonsson (ORCID: https://orcid.org/0000-0003-4197-7566)
- David Luke (ORCID: https://orcid.org/0000-0003-2141-2453)
- Roman Palitsky (ORCID: https://orcid.org/0000-0002-0415-6411)
- Neşe Devenot (ORCID: https://orcid.org/0000-0003-0561-0935)
- Abigail E. Calder (ORCID: https://orcid.org/0000-0001-9528-404X)
- Brian Holoyda (ORCID: https://orcid.org/0000-0002-8634-6090)
- Joost J. Breeksema (ORCID: https://orcid.org/0000-0002-8787-4610)
- Joy Krecké (ORCID: https://orcid.org/0000-0003-0938-7224)
- Ingmar Gorman
- Marc Aixalà
- Jules Evans
- Katherine Cheung (ORCID: https://orcid.org/0009-0003-3529-4109)
- Elin Stahre
- Lisa Burback
Institutions
- Leiden University (NL)
- International Computer Science Institute (US)
- University Medical Center Groningen (NL)
- Johns Hopkins University (US)
- Emory University (US)
- University of Auckland (NZ)
- University of Fribourg (CH)
- University of Alberta (CA)
- University of Groningen (NL)
- University of California, San Francisco (US)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- University of Exeter (GB)
- University of California System (US)
- Karolinska Institutet (SE)
- University of Alabama at Birmingham (US)
- University of Oxford (GB)
- Johns Hopkins Berman Institute of Bioethics (US)
- Multidisciplinary Association for Psychedelic Studies (US)
- Institute of Psychiatry and Neurology (PL)
- Contra Costa Health Services (US)
- Imperial College London (GB)
- University of Greenwich (GB)
- Charité - Universitätsmedizin Berlin (DE)
- University of California, Berkeley (US)
Publication Details
- Journal
- Psychiatric Research and Clinical Practice
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1176/appi.prcp.20240128
- Citations
- 14
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 32.30
Funders
- John Templeton Foundation
- Emory University
- Johns Hopkins University
- Agricultural Technology Adoption Initiative
- Joseph Ben Shimon Foundation
- University of Greenwich
- Steven and Alexandra Cohen Foundation
- University of Alberta
- University of Exeter
- Imperial College London
- University of Oxford
- Universiteit Leiden
- Rijksuniversiteit Groningen
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Karolinska Institutet
- Fundação Bial
- Universitair Medisch Centrum Groningen
- Université de Fribourg
- National Institutes of Health
- University of California, San Francisco
- University at Buffalo
- Johns Hopkins Bloomberg School of Public Health